Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR
Tanya M. Laidlaw, Andrew Menzies‐Gow, Scott Caveney, et al.
Journal of Asthma and Allergy (2023) Vol. Volume 16, pp. 915-932
Open Access | Times Cited: 24

Showing 24 citing articles:

The mucosal concept in chronic rhinosinusitis: Focus on the epithelial barrier
Bing Yan, Feng Lan, Jingyun Li, et al.
Journal of Allergy and Clinical Immunology (2024) Vol. 153, Iss. 5, pp. 1206-1214
Closed Access | Times Cited: 11
Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma Across Multiple Clinically Relevant Subgroups in the NAVIGATOR Study
Tara F. Carr, Wendy C. Moore, Monica Kraft, et al.
Advances in Therapy (2024) Vol. 41, Iss. 7, pp. 2978-2990
Open Access | Times Cited: 7
Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps
Brian J. Lipworth, Joseph K. Han, Martin Desrosiers, et al.
New England Journal of Medicine (2025)
Closed Access
Inflammatory and homeostatic roles of eosinophil subpopulations in chronic rhinosinusitis with nasal polyp pathogenesis
Kantapat Simmalee, Putthapoom Lumjiaktase, Theerasuk Kawamatawong, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Brazilian guideline for the use of immunobiologicals in chronic rhinosinusitis with nasal polyps ‒ 2024 update
Wilma Terezinha Anselmo‐Lima, Fabrizio Ricci Romano, Edwin Tamashiro, et al.
Brazilian Journal of Otorhinolaryngology (2024) Vol. 90, Iss. 3, pp. 101394-101394
Open Access | Times Cited: 4
Tezepelumab improved chronic rhinosinusitis with nasal polyps in a Patient with aspirin exacerbated respiratory disease
Yuga Yamashita, Kosuke Terada, Yuka Kodama, et al.
Respiratory Medicine Case Reports (2024) Vol. 50, pp. 102041-102041
Open Access | Times Cited: 4
Biological therapy in Chronic rhinosinusitis with nasal polyps
Zeyi Jin, Bing Yan, Luo Zhang, et al.
Expert Review of Clinical Immunology (2025)
Closed Access
The immunology of asthma and chronic rhinosinusitis
Atsushi Kato, Hirohito Kita
Nature reviews. Immunology (2025)
Closed Access
Diagnostik und medikamentöse Therapie der chronischen Rhinosinusitis
Sven Becker
HNO (2025)
Open Access
Advancements in biologic therapy in eosinophilic asthma
Rini Patadia, Thomas B. Casale, John R. Fowler, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 4, pp. 251-261
Closed Access | Times Cited: 3
Real-world unified airway benefits of mepolizumab
Jonathan A. Bernstein, Jared Silver, Elizabeth R. Packnett, et al.
Annals of Allergy Asthma & Immunology (2024) Vol. 133, Iss. 4, pp. 422-429.e2
Open Access | Times Cited: 3
Biologics in Aspirin-Exacerbated Respiratory Disease and Allergic Bronchopulmonary Aspergillosis
Jenny Huang, Andrew A. White
Immunology and Allergy Clinics of North America (2024) Vol. 44, Iss. 4, pp. 673-692
Closed Access | Times Cited: 2
Tezepelumab for severe asthma: elevating current practice to recognize epithelial driven profiles
Marco Caminati, Alessandro Vatrella, Paola Rogliani, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
Thymic Stromal Lymphopoietin (TSLP): Evidence in Respiratory Epithelial-driven Diseases Including Chronic Rhinosinusitis with Nasal Polyps
Eugenio De Corso, Peter W. Hellings, Wytske J. Fokkens, et al.
Current Allergy and Asthma Reports (2024) Vol. 25, Iss. 1
Closed Access | Times Cited: 2
Eicosanoids, innate immunity, and alarmins in aspirin-exacerbated respiratory disease
Alexandra E. Conway, Andrew A. White, Larry Borish, et al.
Annals of Allergy Asthma & Immunology (2024) Vol. 133, Iss. 1, pp. 13-15
Closed Access | Times Cited: 1
Antibody-based therapeutics for chronic rhinosinusitis with nasal polyps
Shama Shishodia, Nora Haloob, Claire Hopkins
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 6, pp. 491-502
Closed Access | Times Cited: 1
Biologics in Chronic Rhinosinusitis
J. Boyd, Ashoke Khanwalkar
Immunology and Allergy Clinics of North America (2024) Vol. 44, Iss. 4, pp. 657-671
Closed Access | Times Cited: 1
Role of Thymic Stromal Lymphopoietin in the Pathophysiology of Asthma and Clinical and Biological Effects of Blockade With Tezepelumab
C. Venegas Garrido, Parameswaran Nair, Ignacio Dávila, et al.
Journal of Investigational Allergology and Clinical Immunology (2024) Vol. 34, Iss. 5, pp. 293-302
Open Access
Clinical efficacy and mechanism-of-action of recombinant IFNα-2b, and IFNα-2b in combination with γ-D-glutamyl-L-tryptophan, in chronic polypous rhinosinusitis with comorbid bronchial asthma
Е. В. Безрукова, E. A. Varyushina, М. А. Афлитонов, et al.
Medical Immunology (Russia) (2024) Vol. 26, Iss. 4, pp. 861-872
Open Access
Chronic obstructive pulmonary disease's eosinophilic phenotype: Clinical characteristics, biomarkers and biotherapy
Mauro Maniscalco, Claudio Candia, Pasquale Ambrosino, et al.
European Journal of Internal Medicine (2024)
Closed Access
Effect of Tezepelumab on Sino-Nasal Outcome Test (SNOT)-22 Domain and Symptom-Specific Scores in Patients with Severe, Uncontrolled Asthma and a History of Chronic Rhinosinusitis with Nasal Polyps
Joshua Jacobs, Joseph K. Han, Jason K. Lee, et al.
Advances in Therapy (2024)
Open Access
Biologics treatment for eosinophilic chronic rhinosinusitis complicated by bronchial asthma: Narrative review
Tatsuya Nagano
Respiratory Investigation (2024) Vol. 63, Iss. 1, pp. 35-39
Open Access
Prospects for assessing the level of tissue IgE and the use of biological therapy in children with polypous rhinosinusitis
E. I. Shabelnikova, А Н Пампура, A. I. Asmanov, et al.
Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) (2024) Vol. 69, Iss. 4, pp. 11-15
Open Access
Positioning tezepelumab for patients with severe asthma: from evidence to unmet needs
Carlo Lombardi, Marcello Cottini, Annamaria Bosi, et al.
Journal of International Medical Research (2024) Vol. 52, Iss. 11
Open Access
Update on the Biological and Clinical Relevance of Mast Cells in Chronic Rhinosinusitis with Nasal Polyps
Luca Giovanni Locatello, Silvia Tonon, Valentina Mele, et al.
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2647-2647
Open Access
Page 1

Scroll to top